Problems with cranial base growth, which supports the skull’s structure, can lead to several chronic conditions of the face and upper airway. However, the molecular mechanisms regulating this process remain poorly understood. In a recent study, researchers from the United States use a sophisticated mouse model to understand the role of RUNX2, a master regulator protein, in cranial base growth. Their findings offer new insights into craniofacial malformations and may contribute to identifying potential therapeutic targets.

Tufts University has signed a memorandum of understanding with Indian Institute of Science to establish a framework for the development of a range of possible initiatives jointly pursued by the two institutions.

A new study from a group of scientists led by Queen Mary University of London, published in the British Journal of Psychiatry, found that women with attention-deficit hyperactivity disorder (ADHD) may be at higher risk for premenstrual dysphoric disorder (PMDD). 

The use of this test in clinical practice would allow for the avoidance of side effects and the implementation of more effective treatment. "We've found a way to practice precision medicine with standard chemotherapy," says Geoff Macintyre, a researcher at the Spanish National Cancer Research Centre (CNIO). The research has been published in the journal Nature Genetics. The test will now be validated in a hospital setting, thanks to a new project funded by the Spanish Ministry for Digital Transformation and Public Service.